Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is advancing a pipeline of internally-developed programs with multiple drug candidates now in clinical trials. PIPE-791 is an LPA1 receptor antagonist in clinical development for idiopathic pulmonary fibrosis and chronic pain. PIPE-307 is a selective inhibitor of the M1 receptor in clinical development for relapsing-remitting multiple sclerosis and major depressive disorder. For more information, please visit www.contineum-tx.com. The in vivo biology group at Contineum Therapeutics is currently seeking a Sr. Scientist to join our drug discovery and development team in San Diego. This is a hands-on position with responsibility for the development and execution of in vivo studies focused on evaluating the efficacy of drug candidates. Studies are focused on a broad range of neuroscience, immunology, and inflammatory (NI&I) conditions, including but not limited to neurodegeneration, systemic fibrosis, and peripheral neuropathies. The successful candidate will have expertise in all aspects of in vivo pharmacology and biology and be a strong team player who enjoys scientific discovery and can communicate well in an interdisciplinary environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree